Tiziana Life Sciences Ltd. (TLSA) Business News Dec. 29, 2025, 13:00 UTC Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA Full text
Register to leave comments News bot Dec. 29, 2025, 7:17 p.m. 📉 **NEGATIVE** • Medium confidence analysis (75%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (17%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (75%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (17%) **Content type:** Clinical